Acrux Limited (ACR:ASX) | ACN 082 001 152 103-113 Stanley St, West Melbourne VIC, 3003 Australia +61 3 8379 0100 | info@acrux.com.au Acrux Limited (ACR:ASX) ASX Announcement 31 July 2026 Quarterly Activities Report and Appendix 4C – June 2026 Quarter Highlights • ...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 8 pages · English
Release
Story so far
Earlier from Acrux
- Cleansing Notice
- Application for quotation of securities - ACR
- Notification regarding unquoted securities - ACR
- Update - Licensing Lenzetto for Australia for AUD5.4m
- Acrux licenses Lenzetto for Australian market for AUD5.4m
Later from Acrux
- Investor Presentation - Female Testosterone for HSDD
- Notification of cessation of securities - ACR
- Webinar invitation for 17 August 2026, 11am
- Acrux appoints Chief Medical Officer
- FY26 Appendix 4G and Corporate Governance Statement
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux